Richard M. Wright
Sr. VP & CCO, Celldex Therapeutics.
Companies
- Celldex TherapeuticsSr. VP & CCO Jul 1, 2015 to Jun 17, 20241
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Celldex Therapeutics CLDX20,833 shares2$615.6K at $29.55Nov 13, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 13, 2025Sold 49,298 shares at $24.00 of Celldex Therapeutics2
- Nov 13, 2025Exercised options 15,750 shares at $22.48 of Celldex Therapeutics2
- Nov 13, 2025Exercised options 26,672 shares at $10.38 of Celldex Therapeutics2
- Nov 13, 2025Exercised options 6,876 shares at $9.02 of Celldex Therapeutics2
- Jun 3, 2024Sold 19,264 shares at $33.99 of Celldex Therapeutics3
- Jun 3, 2024Sold 27,580 shares at $33.53 of Celldex Therapeutics3
- Jun 3, 2024Exercised options 18,375 shares at $22.48 of Celldex Therapeutics3
- Jun 3, 2024Exercised options 28,469 shares at $28.00 of Celldex Therapeutics3
- Jun 3, 2024Exercised options 20,625 shares at $2.78 of Celldex Therapeutics3
- Aug 15, 2022Sold 15,328 shares at $37.71 of Celldex Therapeutics4
- Aug 15, 2022Exercised options 15,328 shares at $10.38 of Celldex Therapeutics4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCelldex Therapeutics, Sr. VP & CCO
- 2
- 3SEC EDGARForm 4 filed Jun 5, 2024
- 4SEC EDGARForm 4 filed Aug 17, 2022